Madison Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Sell
14,922
-1,132
-7% -$372K 0.05% 176
2025
Q4
$5.63M Sell
16,054
-546
-3% -$185K 0.06% 159
2025
Q3
$5.36M Sell
16,600
-126,753
-88% -$39.4M 0.06% 161
2025
Q2
$55.8M Sell
143,353
-6,219
-4% -$2.5M 0.6% 54
2025
Q1
$65.1M Buy
149,572
+87,491
+141% +$35.1M 0.72% 49
2024
Q4
$22.9M Sell
62,081
-13,098
-17% -$5.48M 0.26% 87
2024
Q3
$39.1M Sell
75,179
-1,200
-2% -$641K 0.44% 69
2024
Q2
$41.4M Sell
76,379
-3,251
-4% -$1.72M 0.51% 65
2024
Q1
$41.3M Sell
79,630
-23,151
-23% -$11.5M 0.51% 59
2023
Q4
$48.5M Buy
102,781
+2,392
+2% +$1.11M 0.66% 52
2023
Q3
$43.7M Buy
100,389
+6,463
+7% +$2.93M 0.64% 52
2023
Q2
$41.7M Buy
+93,926
New +$43.3M 0.61% 57

Other funds holding ELV

Madison Asset Management's ELV Position: Q1 2026 in Review

Madison Asset Management reduced its Elevance Health (ELV) stake by 7.1% in Q1 2026, selling an estimated $372K and leaving 14,922 shares worth $4.37M. The position accounts for 0.05% of the portfolio, ranked #176.

Madison Asset Management first reported a position in ELV in Q2 2023 and has held it in 12 quarters since. The position peaked at $65.1M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Madison Asset Management held 14,922 shares of Elevance Health worth $4.37M as of Q1 2026.
  • Madison Asset Management sold 1,132 Elevance Health shares in Q1 2026, an estimated $372K.
  • Elevance Health made up 0.05% of Madison Asset Management's portfolio in Q1 2026, its #176 holding.
  • Madison Asset Management first reported a position in Elevance Health in Q2 2023 and has held it in 12 quarters since.
  • Madison Asset Management's Elevance Health position peaked at $65.1M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Madison Asset Management's 13F filing for Q1 2026, filed 7 May 2026.